A Phase 3 Randomized Controlled Trial to Evaluate Efficacy and Safety of New-Formulation Zenon (Rosuvastatin/Ezetimibe Fixed-Dose Combination) in Primary Hypercholesterolemia Inadequately Controlled by Statins

A Phase 3 Randomized Controlled Trial to Evaluate Efficacy and Safety of New-Formulation Zenon (Rosuvastatin/Ezetimibe Fixed-Dose Combination) in Primary Hypercholesterolemia Inadequately Controlled by Statins

Objective: In primary hypercholesterolemia many people treated with statins do not reach their plasma LDL-C goals and are at increased risk of cardiovascular disease (CVD). This study aimed to evaluate efficacy and safety of a new fixed-dose combination (FDC) formulation of rosuvastatin/ezetimibe (R...

Full description

Bibliographic Details
Main Authors: Alberico L. Catapano MD, PhD, Michal Vrablik MD, PhD, Yuri Karpov MD, Baptiste Berthou Lic, Megan Loy BAppSc, Marie Baccara-Dinet MD
Format: Article
Language:English
Published: SAGE Publishing 2022-11-01
Series:Journal of Cardiovascular Pharmacology and Therapeutics
Online Access:https://doi.org/10.1177/10742484221138284

Internet

https://doi.org/10.1177/10742484221138284

Similar Items